San Francisco, CA, United States of America

Jasper Williams

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Arsenal Biosciences, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jasper Williams

Introduction

Jasper Williams is a notable inventor based in San Francisco, CA. He has made significant strides in the field of biotechnology, particularly in the development of immune cell technologies. His work focuses on enhancing the capabilities of immune cells through innovative genetic engineering techniques.

Latest Patents

Jasper Williams holds a patent for "Immune cells having co-expressed shRNAS and logic gate systems." This patent includes recombinant nucleic acids that encode chimeric priming receptors binding to ALPG/P, chimeric antigen receptors that bind to MSLN, and shRNA targeting FAS, PTPN2, and/or TOX. The patent also describes systems of these chimeric receptors and methods for their use, showcasing his commitment to advancing medical science.

Career Highlights

Williams is currently employed at Arsenal Biosciences, Inc., where he continues to push the boundaries of immunotherapy. His work is pivotal in developing new treatments that harness the power of the immune system to combat diseases.

Collaborations

He collaborates with talented individuals such as Aaron Cooper and Adam Litterman, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jasper Williams exemplifies the spirit of innovation in biotechnology through his groundbreaking patent and contributions at Arsenal Biosciences, Inc. His work is paving the way for future advancements in immune cell therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…